University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
6156 Ergebnisse für "full" unter University of Zurich
Implicit bias, full text
... Implicit bias, full text LE _R ~ PUSHING THE FRONTIERS OF INNOVATIVE RESEARCH ADVICE PAPER No.23 ... rank of full professor in the majority of the countries, or otherwise represents the highest post at ... Implicit bias, full text ... Implicit bias, full text LE _R ~ PUSHING THE FRONTIERS OF INNOVATIVE RESEARCH ADVICE PAPER No.23 ... Implicit bias, full text ...
Full Papers | AUTOMATA 2016
... The proceedings containing full papers can be found here . Shigeki Akiyama and Katsunobu Imai The ... Full Papers | AUTOMATA 2016 ... http://automata2016.ini.uzh.ch/ full-papers.html ... Full Papers | AUTOMATA 2016 ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
10681 Ergebnisse für "full" unter Somagenetix
UZH - UZH Journal - In Full Sail
... ; Simona Cerrato, administrative assistant; Nina Cornelius, events and communications. In Full Sail On the ... full sail.” The DSI network has grown to include over 300 UZH researchers, and upwards of 30 professors ... UZH - UZH Journal - In Full Sail ... UZH - UZH Journal - In Full Sail Home Main navigation Search Jump to content Breadcrumb University ... UZH - UZH Journal - In Full Sail ...
52563989
... heavy chain (IGH) locus, leading to overexpression of the full-length protein;3 in contrast, the rare ... survival than the full length isoforms, although our siRNAs were not entirely specific for either one or ... blood-2015-08-662635. full-1.pdf ... https://www.zora.uzh.ch/id/eprint/118783/1/blood-2015-08-662635. full-1.pdf ... blood-2015-08-662635. full-1.pdf ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
3160 Ergebnisse für "full" unter Roche Glycart AG
Roche - Roche on track – full year earnings outlook increased
... You are here: Roche on track – full year earnings outlook increased Group sales stable in local ... Division sales up 5%; on track to meet full-year guidance. Core operating profit up 5% driven primarily by ... Roche - Roche on track – full year earnings outlook increased ... Roche - Roche on track – full year earnings outlook increased We use cookies to give you the best ... Roche - Roche on track – full year earnings outlook increased ...
EURETINA 2021
... professionals outside the US are required to register and log-in to access the full range of content available ... the full suite of MEDICALLY features You have successfully signed up for this alert. You will be ... log-in to access the full range of content available on this website. By clicking on one of the ... the full suite of MED ICALLY features Add to calendar Share page Duration 4mins Virtual Deep Learning ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
3038 Ergebnisse für "full" unter ETH Entrepreneurship
Comments on: Collaboration with Open Systems in full speed
... Comments on: Collaboration with Open Systems in full speed Comments on: Collaboration with Open ... Systems in full speed Zurich Information Security and Privacy Center ... Comments on: Collaboration with Open Systems in full speed ... https://zisc.ethz.ch/2016/06/16/collaboration-with-open-systems-in- full-speed/feed/ ... Comments on: Collaboration with Open Systems in full speed ...
Jonathan Home appointed Full Professor – Department of Physics | ET...
... Jonathan Home appointed Full Professor Jonathan Home appointed Full Professor At its meeting of 11 ... Jonathan Home appointed Full Professor – Department of Physics | ETH Zurich ... https://www.phys.ethz.ch/news-and-events/d-phys-news/2019/12/jonathan-home-appointed- full ... Jonathan Home appointed Full Professor – Department of Physics | ETH Zurich ...
Kuros Biosciences AG
8952 Schlieren, Wagistrasse 25
+41 (0)44 733 4747
Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.
Kuros Biosciences AG
Wagistrasse 25
8952 Schlieren
95 Ergebnisse für "full" unter Kuros Biosciences AG
Kuros Biosciences reports results for the full year 2020 - Kuros Bi...
... results for the full year 2020 Financial highlights CHF 29.8 million cash & cash equivalents, trade and ... available by early 2022 and full (1-yr endpoint) data in the second half of 2022. The annual report 2020 is ... Kuros Biosciences reports results for the full year 2020 - Kuros Biosciences ... https://kurosbio.com/resources/kuros-biosciences-reports-results-for-the- full-year-2020/ ... Kuros Biosciences reports results for the full year 2020 - Kuros Biosciences ...
Comments on: Kuros Biosciences reports results for the full year 2020
... Comments on: Kuros Biosciences reports results for the full year 2020 Comments on: Kuros ... Biosciences reports results for the full year 2020 Eliminating non-unions with targeted and controlled bone ... Comments on: Kuros Biosciences reports results for the full year 2020 ... https://kurosbio.com/resources/kuros-biosciences-reports-results-for-the- full-year-2020/feed/ ... Comments on: Kuros Biosciences reports results for the full year 2020 ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
34 Ergebnisse für "full" unter Bio-Technopark Schlieren-Zürich
Kuros Biosciences reports results for the full year 2022 › BIO-TECH...
... robust progress with its results for full year 2022, increasing MagnetOs direct sales by 75% and ... Kuros Biosciences reports results for the full year 2022 › BIO-TECHNOPARK® Schlieren-Zürich ... https://www.bio-technopark.ch/en/news-en/kuros-biosciences-reports-results-for-the- full-year-2022/ ... Kuros Biosciences reports results for the full year 2022 › BIO-TECHNOPARK® Schlieren-Zürich ...
Molecular Partners Reports Corporate Highlights From Q4 2022 and Ke...
... corporate highlights and audited financial results for the full year 2022. “Our focus in 2023 is the ... Company employed 175.3 FTE ( full-time equivalents), up 7% year-on-year. About 81% of the employees are ... Molecular Partners Reports Corporate Highlights From Q4 2022 and Key Financials for Full Year 2022 › ... -2022-and-key-financials-for- full-year-2022/ ... Molecular Partners Reports Corporate Highlights From Q4 2022 and Key Financials for Full Year 2022 › ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
129 Ergebnisse für "full" unter CSL Vifor
Videos | CSL
... biotherapies that save lives, and help people with life-threatening medical conditions live full lives ... innovative biotherapies that save lives, and help people with life-threatening medical conditions live full ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
157 Ergebnisse für "full" unter University Hospital Zurich, Research and Education Office
Mappe1
... Mappe1 Untersuchte HRD-Gene HRD-Panel (Gene Name) Abdeckung ARID1A full-gene ATM* full-gene ATR ... full-gene ATRX full-gene BAP1 full-gene BRAF HotSpot (NM_004333.4; Exon 11, 12,13, 15) BRCA1* full-gene ... Mappe1 Untersuchte HRD-Gene HRD-Panel (Gene Name) Abdeckung ARID1A full-gene ATM* full-gene ATR ... full-gene ATRX full-gene BAP1 full-gene BRAF HotSpot (NM_004333.4; Exon 11, 12,13, 15) BRCA1* full-gene ...
QMS_Vorlage
... , 01.09.2020 Genliste Oncomine™ BRCA Mutationen BRCA1 BRCA2 Full Full Flyer ... , 01.09.2020 Genliste Oncomine™ BRCA Mutationen BRCA1 BRCA2 Full Full Flyer ...
Topadur Pharma AG
8952 Schlieren, Grabenstrasse 11a
A team dedicated to develop innovative speciality medication for the treatment of severe wound-healing problems enabling significant improvements of patients quality of life. TOPADUR’s lead R&D programs are local active, highly potent, dual mode of action drugs. TOPADUR’s unique development candidates #3;work on validated drug targets resulting in higher than average clinical success chances.
Topadur Pharma AG
Grabenstrasse 11a
8952 Schlieren
4 Ergebnisse für "full" unter Topadur Pharma AG
disease-areas
... Discover the full potential of our scientific research. TOP-N53 ... Discover the full potential of our scientific research. TOP-N53 Foot Diabetic foot ulcer Learn more TOP-N53 ...
Topadur Pharma
... nitric oxide donor and phosphodiesterase 5 inhibitor, and applied it locally to full-thickness skin ... nitric oxide donor and phosphodiesterase 5 inhibitor, and applied it locally to full-thickness skin ...
Dinamiqs – a Siegfried company
8952 Schlieren, Wagistrasse 25
We are a science-driven contract development and manufacturing organization offering end-to-end viral vector manufacturing solutions. We offer customized services for companies and institutions developing innovative genetic medicines. As a science and technology-driven platform, we provide a comprehensive approach to viral vector manufacturing, from lab-scale development to scalable bioreactor implementation, process optimization, formulation, and stringent quality control.
Dinamiqs – a Siegfried company
Wagistrasse 25
8952 Schlieren
13 Ergebnisse für "full" unter Dinamiqs – a Siegfried company
... full capsids containing the gene of interest. To address this, we employed mass photometry (MP) as a ... rapid and precise method to distinguish empty, partial, and full rAAVs based on their mass distribution ... full capsids containing the gene of interest. To address this, we employed mass photometry (MP) as a ... rapid and precise method to distinguish empty, partial, and full rAAVs based on their mass distribution ...
Implementing the SamuxMP mass photometer - DINAMIQS
... enables fast and accurate measurement of the full/empty rAAV particle ratio. The understanding of this ... Development, Marco Wachowius says “Using mass photometry, we are now able to determine the ratio between full ... scattering microscopy, which enables fast and accurate measurement of the full/empty rAAV particle ratio. The ... the ratio between full and empty rAAV capsids with unparalleled speed and accuracy. This technology ...
